Mariana Madanelo

Mariana Madanelo

Auto-generated profile, based on publicly available information

Mariana Madanelo

Urology Department, Centro Hospitalar e Universitário de Santo António, Unidade Local de Saúde de Santo António, Porto

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2020 in BJU International
Verified
Journal Article
Closed access
PDF file
MMMariana Madanelo
Mariana Madanelo
CFCarlos Ferreira
Carlos Ferreira
DNDiogo Nunes‐Carneiro
Diogo Nunes‐Carneiro
APAndré Pinto
André Pinto
MRMaria Alexandra Rocha
Maria Alexandra Rocha
AFAvelino Fraga
Avelino Fraga

19 May 2023 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
PLPierre Lecoanet
Pierre Lecoanet
MMMariana Madanelo
Mariana Madanelo
TTThibault Tricard
Thibault Tricard
AVAnne Mauger de Varennes
Anne Mauger de Varennes
CHCamille Haudebert
Camille Haudebert
BPBenoit Peyronnet
Benoit Peyronnet

25 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GMGonçalo Mendes
Gonçalo Mendes
MMMariana Madanelo
Mariana Madanelo
FVFernando Vila
Fernando Vila
RVRui Versos
Rui Versos
BTBernardo Lobão Teixeira
Bernardo Lobão Teixeira
MSMiguel Silva-Ramos
Miguel Silva-Ramos
Purpose: The aim of our study is to compare the perioperative, functional, and oncological outcomes of laparoscopic transperitoneal partial nephrectomy (LTPN) and laparoscopic retroperitoneal partial nephrectomy (LRPN) for posterior cT1 renal tumors. Methods: We retrospectively collected data on all patients who consecutively underwent LTPN and LRPN for posterior cT1 renal tumors in three different centers from January 2015 to January 2023. Patients with a single, unilateral, cT1 renal mass, located in the posterior renal surface were included. Patients’ data regarding perioperative, functional, and oncological outcomes were collected from medical records and statistically analyzed and compared. Results: A total of 128 patients was obtained, with 53 patients in the LPTN group and 75 patients in the LRPN group. Baseline characteristics were similar. Warm ischemia time (WIT) (18.8 vs. 22.6 min, p = 0.002) and immediate postoperative eGFR drop (−6.1 vs. −13.0 mL/min/1.73 m2, p = 0.047) were significantly lower in the LPTN group. Estimated blood loss (EBL) (100 vs. 150 mL, p = 0.043) was significantly lower in the LRPN group. All other perioperative and functional outcomes and complications were similar between the groups. The positive surgical margin (PSM) rate was lower in the LRPN group, although without statistical significance (7.2% vs. 13.5%, p = 0.258). Surgical success defined by Trifecta (WIT ≤ 25 min, no PSM, and no major postoperative complication) was similar between both approaches. Conclusions: LTPN has significantly shorter WIT and a significantly smaller drop in immediate eGFR when compared to LRPN for posterior renal tumors. On the other hand, LRPN has significantly less EBL than LTPN. LRPN demonstrated fewer PSMs than LTPN, albeit without statistical significance. In terms of overall surgical success, as defined by Trifecta, both approaches achieved similar results.

14 September 2022 in Central European Journal of Urology
Verified
Journal Article
Open access
JCJorge Correia
Jorge Correia
GMGonçalo Mendes
Gonçalo Mendes
BTBernardo Texeira
Bernardo Texeira
MMMariana Madanelo
Mariana Madanelo
AFAvelino Fraga
Avelino Fraga
MSMiguel Silva-Ramos
Miguel Silva-Ramos
The Central European Journal of Urology is an open access quarterly-issued journal, which provides a forum for the presentation of original clinical, experimental and other research studies...

Verified
Journal Article
Open access
PDF file
GMGonçalo Mendes
Gonçalo Mendes
BTBernardo Teixeira
Bernardo Teixeira
MMMariana Madanelo
Mariana Madanelo
ARAlexandra Rocha
Alexandra Rocha
SMSofia Mesquita
Sofia Mesquita
NLNuno Louro
Nuno Louro
Purpose: To evaluate the influence of testicular cancer histology and stage on sperm parameters in cryopreserved samples collected prior to orchiectomy. Materials and methods: We conducted a retrospective analysis of tumor histology, stage and sperm parameters of patients who underwent pre-orchiectomy sperm cryopreservation for testicular cancer between March 2010 and March 2023. The World Health Organization (WHO) 2010 sperm reference values were used to identify patients with subnormal semen parameters and to further categorize patients by sperm alteration. Localized disease was classified as Stage I, while metastatic disease encompassed Stages II and III. Continuous variables were compared using t-test or Mann Whitney U test, and categorical variables using Chi-square and Fishers exact test. Results: A total of 64 patients was identified, 48 (75%) classified as stage I and 16 (25%) classified as stage II/III. No difference was found in semen parameters between patients with seminoma and patients with non-seminoma germ cell tumor (NSGCT). Patients with stage II/III disease had significantly lower percentages of progressive motility (36% vs 53%, p=0.021) and total motility (60% vs 69%, p=0.015) than stage I patients. When categorizing by sperm alterations according to WHO 2010 reference values, patients with stage II/III disease had significantly higher proportions of asthenozoospermia (38% vs 15%, p=0.048) and teratozoospermia (63% vs 31%, p=0.027) than stage I patients. Elevated tumor markers were not associated with sperm abnormalities. Conclusions: Patients with metastatic testicular cancer present with worse sperm quality than patients with localized disease. Sperm cryopreservation should be offered to all patients with testicular cancer, and especially emphasized in patients with metastatic disease.

Verified
Journal Article
Open access
PDF file
ARAlexandra Rocha
Alexandra Rocha
GMGonçalo Mendes
Gonçalo Mendes
SMSofia Mesquita
Sofia Mesquita
MMMariana Madanelo
Mariana Madanelo
JVJoão Vital
João Vital
AFAvelino Fraga
Avelino Fraga
Background: Ureteral stents are one of the most used devices in Urology, allowing drainage of the upper urinary system, and can be used either in elective or emergency procedures. However, as a foreign body inside the urinary system, they are subject to encrustation. Encrustation is one of the burdens seen with double-J stents and, to date, there is no consensus about its best management. This study aims to prove that Endoscopic Combined Intra-Renal Surgery (ECIRS) is the best choice when there’s an encrusted proximal loop of a ureteral stent. Methods: The authors conducted a retrospective cohort study of patients with an encrusted proximal loop of the ureteral stent who underwent surgery at a single center, comparing ECIRS with other procedures. Results: Between July 2011 and June of 2024, 33 patients (18 females and 15 males) were submitted to surgery. The median indwelling time of the stent was 11 (8-19) months and a stentfree rate of 100% was achieved. The authors demonstrated a significant stone-free rate of 61.1% following ECIRS compared to merely 20% with other procedures (p = 0.023). Notably, while the complication rate was low across all procedures, the ECIRS group exhibited fewer complications (5.6%) than those undergoing alternate techniques (13.3%), though this difference was not statistically significant (p = 0.439). Conclusions: Our study advocates for ECIRS as the preferred initial treatment for encrusted proximal ureteral stents, as it facilitates superior stone clearance, minimizes complications, and maintains comparable operative efficiency. This research contributes valuable insights into the management of challenging cases involving encrusted ureteral stents, calling for future studies to further validate these findings.